A scoping review of 22 U.S. studies finds that hands-on workshops, digital learning tools, and diverse skin tone content are ...
Dublin, Oct. (GLOBE NEWSWIRE) -- "Cardiovascular Clinical Trials Market Size, Share & Trends Analysis Report by Phase, Study Design, Indication by Study Design, Indication, Service, Sponsor, Region, ...
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense" or the "Company"), a biotechnology company developing treatments ...
A position paper argues that radiochemical robustness, not just peak radiochemical yield, should be a co-equal design ...
Digitalization at the University Medical Center Mainz (UM), as part of its future programme UM.Digital, has reached another ...
ProQR Therapeutics N.V. announced upcoming presentations highlighting clinical and preclinical progress with AX-0810 and ...
United Therapeutics Corporation (NASDAQ:UTHR) has received clearance from the U.S. Food and Drug Administration (FDA) to ...
Parexel’s Stacy Hurt draws on her experience with chemotherapy and as a caregiver to spot patient burdens that AI-assisted ...
ProQR to present its ADAR-mediated RNA editing approach and progress toward next-generation editing oligonucleotides at TIDES Europe plenary ...
When the Michael J. Fox Foundation for Parkinson’s Research launched a major study in 2010, the objective was to help ...
Drug development is a stepwise process, with each clinical phase answering a different question about a treatment's safety ...
Vera Health raises $28.5M in Series A funding led by Threshold Ventures to scale its evidence-graded clinical AI search ...